In vivo optical imaging of CD13/APN-expression in tumor xenografts

Authors:

Abstract
Optical imaging is a desirable technique for in vivo cancer diagnostics since it is a highly sensitive, inexpensive imaging method that can potentially resolve relevant oncological target structures in vivo.1 With the injection of a fluorescent compound (fluorochrome), optical imaging allows specific tagging of particular receptors, antibodies, genes, or drugs, thereby measuring compound biodistribution and pharmacokinetics and hence leading to a better understanding of these processes.1, 2, 3, 4 Combining new quantitative fluorescence imaging methods with target specific fluorochromes facilitates the visualization and quantification of specific receptor expression in vivo. Especially, fluorescence mediated tomography (FMT) as a newly emerging optical imaging technique has been shown to be capable of resolving fluorescence signatures three-dimensionally and quantitatively.5, 6, 7, 8, 9

This publication has 30 references indexed in Scilit: